ENTITY
Ascletis Pharma Inc

Ascletis Pharma Inc (1672 HK)

67
Analysis
Health CareChina
Ascletis Pharma Inc. operates as a biotechnology company. The Company develops and discovers anti-viral drugs to address unmet medical needs in anti-viral, cancer, and fatty liver disease. Ascletis Pharma offers its services worldwide.
more
bullishGreentown China
18 Mar 2020 12:38

Asia-Pac Stocks Priced For Liquidation

When investors are chucking in the towel, including the event space (RV, risk arb etc.), it's time for some old school perspective. In this...

Logo
746 Views
Share
27 Feb 2020 10:09

SELL Ascletis Pharma: Why the COVID-19 Update Does Not Make Sense

We have previously discussed the short idea of Ascletis Pharma. After a few days of retreat, the stock reacted positively today to the news related...

Logo
342 Views
Share
14 Feb 2020 17:32

HK - Shorts Pile Into Tencent, CCB, Ping An, Sunny Optical, AIA; Cover Mobile, China Tower, BYD

We take a look at the latest SFC data released today evening on short position reporting in Hong Kong for the week ended 7 February 2020.Total...

Logo
392 Views
Share
13 Feb 2020 17:22

Ascletis Pharma: Reiterate Sell, 29% Downside

We have previously discussed the short idea of Ascletis Pharma. Today the stock reacted positively to the news that it received approval from the...

Logo
389 Views
Share
07 Feb 2020 17:03

HK - Action in Anta, China Gas, Sunny Optical, Ascletis Pharma, Sa Sa, CMS

We take a look at the latest SFC data released today evening on short position reporting in Hong Kong for the week ended 31 January 2020.Total...

Logo
403 Views
Share
x